The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Alnylam Pharmaceuticals Inc COM 02043Q107 1,238 33,065 SH   DFND 1 33,065 0 0
Calpine Corp CALL 131347904 8,744 765,000 SH   DFND 1 0 0 0
Calpine Corp COM NEW 131347304 15,084 1,319,723 SH   DFND 1 1,319,723 0 0
Calpine Corp COM NEW 131347304 2,531 221,450 SH   DFND   221,450 0 0
DaVita HealthCare Partners Inc COM 23918K108 6,330 98,605 SH   DFND 1 98,605 0 0
DaVita HealthCare Partners Inc COM 23918K108 1,038 16,171 SH   DFND   16,171 0 0
Kraft Heinz Co CALL 500754906 24,188 277,000 SH   DFND 1 0 0 0
The Medicines Co COM 584688105 3,763 110,883 SH   DFND 1 110,883 0 0
Retrophin Inc COM 761299106 3,100 163,741 SH   DFND 1 163,741 0 0
Seritage Growth Properties CL A 81752R100 6,320 147,972 SH   DFND 1 147,972 0 0
Seritage Growth Properties CL A 81752R100 834 19,528 SH   DFND   19,528 0 0
TripAdvisor Inc COM 896945201 7,619 164,300 SH   DFND 1 164,300 0 0
TripAdvisor Inc COM 896945201 881 19,000 SH   DFND   19,000 0 0